Clinical Trials Logo

Compression Neuropathy clinical trials

View clinical trials related to Compression Neuropathy.

Filter by:
  • None
  • Page 1

NCT ID: NCT06294821 Not yet recruiting - Clinical trials for Carpal Tunnel Syndrome

4AP to Delay Carpal Tunnel Release (CTR)

CTR
Start date: September 2024
Phase: Phase 2/Phase 3
Study type: Interventional

The investigators have found recent promising data supporting the use of a currently FDA approved drug, 4-aminopyridine, in the treatment of nerve injury including compression neuropathy. The purpose of this research is determine whether 4-aminopyridine can delay the need for formal surgical release in patients with known carpal tunnel syndrome who would otherwise undergo surgery.

NCT ID: NCT02141035 Completed - Clinical trials for Carpal Tunnel Syndrome

Acetyl-l-carnitine to Enhance Nerve Regeneration in Carpal Tunnel Syndrome

Start date: September 2015
Phase: Phase 2/Phase 3
Study type: Interventional

Study Hypothesis: Acetyl-l-carnitine increases nerve regeneration in patients with severe carpal tunnel syndrome. Carpal tunnel syndrome (CTS) is common, affecting almost 3% of the general population. In severe cases, nerve regeneration and functional recovery are incomplete even with surgery. The goal of this pilot project is to test a potentially promising medication, acetyl-l-carnitine (ALCAR). We will use a randomized, double blinded, placebo controlled study design. Along with surgery, those in the treatment group will also receive ALCAR while the other half in the control group will be given placebo. To gauge the effects of ALCAR, we will compare motor and sensory nerve growth as well as functional outcomes. The data from this study will provide crucial information when designing a full scale clinical trial. If successful, this will represent an important first step in finding a novel treatment to improve functional outcomes in patients with severe CTS.